drugset / Trial / NCT01439074

Mepilex Ag Versus Silver Sulfadiazine in Children and Adults With Burn Injuries.

NCT01439074

Completed 162 enrolled Molnlycke Health Care AB
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose is to compare time to healing using absorbent foam silver dressing (Mepilex Ag) compared to a silver sulfadiazine (SSD) 1% cream in the treatment of partial thickness burn injuries.284 in-patients in 8-12 centres in China will be evaluated. Treatment period will be up to 4 weeks with either Mepilex Ag or SSD.

Timeline

Start
2011-09
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silver Sulfadiazine Small molecule 1 %

Indications

No indication recorded.